JPMorgan analyst Seth Seifman initiated coverage of MDA Space (MDA) with an Overweight rating and $34 price target which implies 25% upside. MDA’s satellite business has “significant potential for growth” due to new capacity give its exposure to both commercial and military demand, the analyst tells investors in a research note. The firm says the company’s legacy robotics business remains a leader while new observation satellites “should reinforce a profitable franchise amid rising demand.” MDA ended 2025 with minimal leverage and its recent equity raise leaves cash for acquisitions, adds JPMorgan.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDA:
- Buy Rating on MDA: Strong Fundamentals, Strengthened Balance Sheet, and Multi‑Year Growth Backed by Backlog and LEO Leadership
- Impact on MDA Space from NASA’s Gateway pause ‘limited,’ says RBC Capital
- MDA Space says Artemis contract with Canada, not NASA
- MDA Space announces exercise of over-allotment option in IPO
- MDA Space awarded contract with Canada’s Defence Investment Agency
